Platelets in sepsis

Sepsis

Volumn 3, Issue 2, 1999, Pages 143-146

  DeLa Cadena, Raul A ^a   Colman, Robert W ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA THROMBOGLOBULIN; ENDOTOXIN; LACTOFERRIN; LEUKOCYTE ELASTASE; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; CELL FUNCTION; ENDOTHELIUM CELL; ENDOTOXEMIA; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THROMBOCYTE; THROMBOCYTE ACTIVATION;

EID: 0033511771     PISSN: 13850229     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009803617259     Document Type: Article

References (27)

1. Parrillo JE, et al. Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy [see comments]. Ann Intern Med 1990;113(3): 227-242.
2. Machiedo GW, et al. Patterns of mortality in a surgical intensive care unit. Surg Gynecol Obstet 1981;152(6):757-759.
3. Knaus WA, et al. Prognosis in acute organ-system failure. Ann Surg 1985;202(6):685-693.
4. Suffredini AF, et al. Effects of recombinant dimeric TNF receptor on human inflammatory responses following intravenous endotoxin administration. J Immunol 1995;155(10): 5038-5045.
5. DeLa Cadena RA, et al. Recombinant tumor necrosis factor receptor p75 fusion protein (TNFR:Fc) alters endotoxin-induced activation of the kinin, fibrinolytic, and coagulation systems in normal humans. Thromb Haemost 1998;80(1): 114-118.
6. Inoue K, et al. Signal transduction pathways mediated by glycoprotein Ia/IIa in human platelets: Comparison with those of glycoprotein VI. Biochem Biophys Res Commun 1999;256(1):114-120.
7. Pytela R, et al. Platelet membrane glycoprotein IIb/IIIa: Member of a family of Arg-Gly-Asp-specific adhesion receptors. Science 1986;231(4745):1559-1562.
8. Ikeda H. Platelet membrane protein CD36 [In Process Citation]. Hokkaido Igaku Zasshi 1999;74(2):99-104.
9. Colman RW. Platelet receptors. Hematol Oncol Clin North Am 1990;4(1):27-42.
10. Knight CG, et al. Collagen-platelet interaction: Gly-Pro-Hyp is uniquely specific for platelet Gp VI and mediates platelet activation by collagen. Cardiovasc Res 1999;41(2):450-457.
11. Adelstein RS, Conti MA. Phosphorylation of platelet myosin increases actin-activated myosin ATPase activity. Nature 1975;256(5518):597-598.
12. Holmsen H, Kaplan KL, Dangelmaier CA. Differential energy requirements for platelet responses. A stimultaneous study of aggregation, three secretory processes, arachidonate liberation, phosphatidylinositol breakdown and phosphatidate production. Biochem J 1982;208(1):9-18.
13. Holmsen H, Dangelmaier CA, Rongved S. Tight coupling of thrombin-induced acid hydrolase secretion and phosphatidate synthesis to receptor occupancy in human platelets. Biochem J 1984;222(1):157-167.
14. Tracy PB, Mann KG. Prothrombinase complex assembly on the platelet surface is mediated through the 74,000-dalton component of factor Va. Proc Natl Acad Sci USA 1983; 80(8):2380-2384.
15. Neuenschwander P, Jesty J. A comparison of phospholipid and platelets in the activation of human factor VIII by thrombin and factor Xa, and in the activation of factor X. Blood 1988;72(5):1761-1770.
16. Cerletti C, et al. Platelet activation by polymorphonuclear leukocytes: Role of cathepsin G and P-selectin. Thromb Haemost 1995;74(1):218-223.
17. Lundahl TH, et al. Activated platelets and impaired platelet function in intensive care patients analyzed by flow cytometry. Blood Coagul Fibrinolysis 1996;7(2):218-220.
18. Gawaz M, et al. Platelet function in septic multiple organ dysfunction syndrome. Intensive Care Med 1997;23(4):379-385.
19. Ono S, Mochizuki H, Tamakuma S. A clinical study on the significance of platelet-activating factor in the pathophysiology of septic disseminated intravascular coagulation in surgery. Am J Surg 1996;171(4):409-415.
20. Merten M, et al. Platelet microparticles promote platelet interaction with subendothelial matrix in a glycoprotein IIb/IIIa-dependent mechanism. Circulation 1999;99(19): 2577-2582.
21. Suffredini AF. Current prospects for the treatment of clinical sepsis. Crit Care Med 1994;22(7):S12-8.
22. Suffredini AF. Myocardial dysfunction in sepsis: Clinical and experimental investigations. Schweiz Med Wochenschr 1998;128(39):1444-1452.
23. van der Poll T, et al. Effect of a recombinant dimeric tumor necrosis factor receptor on inflammatory responses to intravenous endotoxin in normal humans. Blood 1997;89(10): 3727-3734.
24. Taveira da Silva AM, et al. Brief report: Shock and multiple-organ dysfunction after self-administration of Salmonella endotoxin [see comments]. N Engl J Med 1993;328(20): 1457-1460.
25. Gawaz M, et al. Platelet activation and interaction with leucocytes in patients with sepsis or multiple organ failure. Eur J Clin Invest 1995;25(11):843-851.
26. Molino M, et al. Proteolysis of the human platelet and endothelial cell thrombin receptor by neutrophil-derived cathepsin G. J Biol Chem 1995;270(19):11168-11175.
27. DeLa Cadena RA, et al. Activation of the kallikrein-kinin system after endotoxin administration to normal human volunteers. Blood 1993;81(12):3313-3317.